Insight Into Market Ahead - Equity Research on Dendreon Corporation and Pharmaceutical Product Development, Inc.
(firmenpresse) - HONG KONG -- (Marketwire) -- 08/17/11 -- Today, released its industry report highlighting Dendreon Corporation (NASDAQ: DNDN) and Pharmaceutical Product Development, Inc. (NASDAQ: PPDI). Full fundamental and technical analysis is available at .
Continued confidence in long-term U.S. debt is defying S&P's recent downgrade. Treasury yields continue at their lowest levels since January 1, 2011 as the market moved to "safe investments" weary of the storm clouds ahead. Winds can change however, as a last-minute move to save the U.S. from a historic default on its debt obligations. Attentions are now turned to the situation in Europe, with the health of the Euro in the balance; bankers are looking to prevent defaults on Italian and Spanish debt.
As a result of recent credit adjustments, opportunity is being marked for investors to take advantage of equities with high-margin and specialty products. Market-wise investors are carefully watching for value within equities boasting established pipelines and excellent growth prospects. As part of this process, the following companies have been introduced with initial research reports available online.
World Street Fundamentals has highlighted Dendreon Corporation as a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients. The Company's product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers. The entire report on Dendreon Corporation (NASDAQ: DNDN) is available here: .
World Street has featured Pharmaceutical Product Development, Inc. as a global contract research organization providing drug discovery, development and lifecycle management services. The Company's clients and partners include pharmaceutical, biotechnology, medical device, academic, non-profit and government organizations. The entire report on Pharmaceutical Product Development, Inc. (NASDAQ: PPDI) is available here: .
About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets.
Contact:
Adam Redford
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 17.08.2011 - 13:00 Uhr
Sprache: Deutsch
News-ID 47516
Anzahl Zeichen: 0
contact information:
Town:
HONG KONG
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 178 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Insight Into Market Ahead - Equity Research on Dendreon Corporation and Pharmaceutical Product Development, Inc."
steht unter der journalistisch-redaktionellen Verantwortung von
World Street Fundamentals (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
